Surprisingly, even in the subgroup of patients without renal dysfunction, higher urinary levels of L-FABP were associated with the progression of DN, demonstrating the usefulness of urinary L-FABP as a marker for predicting the progression of DN in the early stage [54]. Here, FABP1 is linked to Abnormal renal physiology.